Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target

American Journal of Pathology

Volumn 177, Issue 3, 2010, Pages 1422-1435

  Desai, Maya K ^a   Mastrangelo, Michael A ^a   Ryan, Deborah A ^a   Sudol, Kelly L ^a   Narrow, Wade C ^a   Bowers, William J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[1-42] ANTIBODY; AMYLOID PRECURSOR PROTEIN; ANTIBODY; CASPASE 3; MYELIN; PARVOVIRUS VECTOR; PRESENILIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; GENE MUTATION; MALE; MOUSE; MYELINATION; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; TRANSGENE;

EID: 77956502794     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100087     Document Type: Article

References (48)

1. Dickerson BC, Sperling RA: Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies. Neuropsychologia 2008, 46:1624-1635
2. de Leeuw FE, Barkhof F, Scheltens P: White matter lesions and hippocampal atrophy in Alzheimer's disease. Neurology 2004, 62:310-312 (Pubitemid 38167149)
3. Roth AD, Ramirez G, Alarcon R, Von Bernhardi R: Oligodendrocytes damage in Alzheimer's disease: beta amyloid toxicity and inflammation. Biol Res 2005, 38:381-387
4. Roher AE, Weiss N, Kokjohn TA, Kuo YM, Kalback W, Anthony J, Watson D, Luehrs DC, Sue L, Walker D, Emmerling M, Goux W, Beach T: Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. Biochemistry 2002, 41:11080-11090 (Pubitemid 35034009)
5. Desai MK, Sudol KL, Janelsins MC, Mastrangelo MA, Frazer ME, Bowers WJ: Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology. Glia 2009, 57:54-65
6. Villain N, Desgranges B, Viader F, de la Sayette V, Mezenge F, Landeau B, Baron JC, Eustache F, Chetelat G: Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. J Neurosci 2008, 28:6174-6181
7. DeToledo-Morrell L, Stoub TR, Wang C: Hippocampal atrophy and disconnection in incipient and mild Alzheimer's disease. Prog Brain Res 2007, 163:741-753
8. Bartzokis G, Lu PH, Mintz J: Quantifying age-related myelin breakdown with MRI: novel therapeutic targets for preventing cognitive decline and Alzheimer's disease. J Alzheimers Dis 2004, 6:S53-59
9. Bartzokis G: Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease, Neurobiol Aging 2004, 25:5-18; author reply 49-62
10. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM: Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 2003, 39:409-421
11. Mastrangelo MA, Bowers WJ: Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's diseaserelated pathologies in male triple-transgenic mice. BMC Neurosci 2008, 9:81
12. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM: Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 2005, 45:675-688 (Pubitemid 40320703)
13. Lee JT, Xu J, Lee JM, Ku G, Han X, Yang DI, Chen S, Hsu CY: Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol 2004, 164:123-131 (Pubitemid 38082463)
14. Xu J, Chen S, Ahmed SH, Chen H, Ku G, Goldberg MP, Hsu CY: Amyloid-beta peptides are cytotoxic to oligodendrocytes, J Neurosci 2001, 21:RC118
15. Jantaratnotai N, Ryu JK, Kim SU, McLarnon JG: Amyloid beta peptide-induced corpus callosum damage and glial activation in vivo. Neuroreport 2003, 14:1429-1433 (Pubitemid 37083122)
16. Lin T, Xiang Z, Cui L, Stallcup W, Reeves SA: New mouse oligodendrocyte precursor (mOP) cells for studies on oligodendrocyte maturation and function. J Neurosci Methods 2006, 157:187-194 (Pubitemid 44331964)
17. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM: Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 2003, 24:1063-1070 (Pubitemid 37487883)
18. Sudol KL, Mastrangelo MA, Narrow WC, Frazer ME, Levites YR, Golde TE, Federoff HJ, Bowers WJ: Generating differentially targeted amyloid-beta specific intrabodies as a passive vaccination strategy for Alzheimer's disease. Mol Ther 2009, 17:2031-2040
19. Malone J, Sullivan MA: Analysis of antibody selection by phage display utilizing anti- phenobarbital antibodies. J Mol Recognit 1996, 9:738-745 (Pubitemid 126447035)
20. Urabe M, Nakakura T, Xin KQ, Obara Y, Mizukami H, Kume A, Kotin RM, Ozawa K: Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells. J Virol 2006, 80:1874-1885 (Pubitemid 43228727)
21. Peterson EB, Mastrangelo MA, Federoff HJ, Bowers WJ: Neuronal specificity of HSV/sleeping beauty amplicon transduction in utero is driven primarily by tropism and cell type composition. Mol Ther 2007, 15:1848-1855
22. Baumann N, Pham-Dinh D: Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 2001, 81:871-927 (Pubitemid 32267079)
23. Su JH, Zhao M, Anderson AJ, Srinivasan A, Cotman CW: Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. Brain Res 2001, 898:350-357 (Pubitemid 32299965)
24. Rohn TT, Rissman RA, Head E, Cotman CW: Caspase activation in the Alzheimer's disease brain: tortuous and torturous. Drug News Perspect 2002, 15:549-557 (Pubitemid 36025540)
25. Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S, Reier PJ, Mandel RJ, Muzyczka N: Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 2004, 10:302-317
26. Hadaczek P, Kohutnicka M, Krauze MT, Bringas J, Pivirotto P, Cunningham J, Bankiewicz K: Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain. Hum Gene Ther 2006, 17:291-302
27. Cunningham J, Oiwa Y, Nagy D, Podsakoff G, Colosi P, Bankiewicz KS: Distribution of AAV-TK following intracranial convection-enhanced delivery into rats. Cell Transplant 2000, 9:585-594 (Pubitemid 32002567)
28. Hinman JD, Chen CD, Oh SY, Hollander W, Abraham CR: Age-dependent accumulation of ubiquitinated 2′,3′-cyclic nucleotide 3′-phosphodiesterase in myelin lipid rafts. Glia 2008, 56:118-133 (Pubitemid 350172737)
29. Wang DS, Bennett DA, Mufson EJ, Mattila P, Cochran E, Dickson DW: Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline. Neurosci Res 2004, 48:93-100 (Pubitemid 37547976)
30. Sloane JA, Hinman JD, Lubonia M, Hollander W, Abraham CR: Age-dependent myelin degeneration and proteolysis of oligodendrocyte proteins is associated with the activation of calpain-1 in the rhesus monkey. J Neurochem 2003, 84:157-168 (Pubitemid 36182076)
31. Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings JL: Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol Aging 2004, 25:843-851
32. Song SK, Kim JH, Lin SJ, Brendza RP, Holtzman DM: Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition. Neurobiol Dis 2004, 15:640-647
33. Redwine JM, Kosofsky B, Jacobs RE, Games D, Reilly JF, Morrison JH, Young WG, Bloom FE: Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis. Proc Natl Acad Sci USA 2003, 100:1381-1386 (Pubitemid 36184010)
34. Gotz J, Ittner LM, Kins S: Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease? J Neurochem 2006, 98:993-1006
35. Wirths O, Weis J, Szczygielski J, Multhaup G, Bayer TA: Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease. Acta Neuropathol 2006, 111:312-319
36. Steele PM, Mauk MD: Inhibitory control of LTP and LTD: stability of synapse strength. J Neurophysiol 1999, 81:1559-1566
37. Stanton PK: LTD. LTP, and the sliding threshold for long-term synaptic plasticity. Hippocampus 1996, 6:35-42
38. Pak KJ, Chan SL, Mattson MP: Homocysteine and folate deficiency sensitize oligodendrocytes to the cell death-promoting effects of a presenilin-1 mutation and amyloid beta-peptide. Neuromolecular Med 2003, 3:119-128
39. Guo Q, Sebastian L, Sopher BL, Miller MW, Ware CB, Martin GM, Mattson MP: Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation. J Neurochem 1999, 72:1019-1029 (Pubitemid 29085016)
40. Pak K, Chan SL, Mattson MP: Presenilin-1 mutation sensitizes oligodendrocytes to glutamate and amyloid toxicities, and exacerbates white matter damage and memory impairment in mice. Neuromolecular Med 2003, 3:53-64 (Pubitemid 37070582)
41. Mela A, Goldman JE: The tetraspanin KAI1/CD82 is expressed by late-lineage oligodendrocyte precursors and may function to restrict precursor migration and promote oligodendrocyte differentiation and myelination. J Neurosci 2009, 29:11172-11181
42. Butts BD, Houde C, Mehmet H: Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease. Cell Death Differ 2008, 15:1178-1186 (Pubitemid 351850971)
43. Zeng C, Lee JT, Chen H, Chen S, Hsu CY, Xu J: Amyloid-beta peptide enhances tumor necrosis factor-alpha-induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes. J Neurochem 2005, 94:703-712
44. Laird FM, Cai H, Savonenko AV, Farah MH, He K, Melnikova T, Wen H, Chiang HC, Xu G, Koliatsos VE, Borchelt DR, Price DL, Lee HK, Wong PC: BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J Neurosci 2005, 25:11693-11709 (Pubitemid 43098462)
45. Hu X, Hicks CW, He W, Wong P, Macklin WB, Trapp BD, Yan R: Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci 2006, 9:1520-1525
46. Wang H, Song L, Laird F, Wong PC, Lee HK: BACE1 knock-outs display deficits in activity-dependent potentiation of synaptic transmission at mossy fiber to CA3 synapses in the hippocampus. J Neurosci 2008, 28:8677-8681
47. Lai C, Feng L: Implication of gamma-secretase in neuregulin-induced maturation of oligodendrocytes. Biochem Biophys Res Commun 2004, 314:535-542 (Pubitemid 38084751)
48. Watkins TA, Emery B, Mulinyawe S, Barres BA: Distinct stages of myelination regulated by gamma-secretase and astrocytes in a rapidly myelinating CNS coculture system. Neuron 2008, 60:555-569